Delta-like 1-Lysine613 Regulates Notch Signaling

Por Zhang, Liguo, Widau, Ryan C., Herring, B. Paul, Gallagher, Patricia J.
Publicado em 2011

Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-associated Protein Kinase (DAPK) in Ceramide-induced Anoikis

Por Widau, Ryan C., Jin, Yijun, Dixon, Shelley A., Wadzinski, Brian E., Gallagher, Patricia J.
Publicado em 2010

p19(Arf) Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms

Por Widau, Ryan C., Zheng, Yanbin, Sung, Caroline Y., Zelivianskaia, Anna, Roach, Lauren E., Bachmeyer, Karen M., Abramova, Tatiana, Desgardin, Aurelie, Rosner, Andrew, Cunningham, John M., Skapek, Stephen X.
Publicado em 2012

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

Por Arkenau, Hendrik‐Tobias, Martin‐Liberal, Juan, Calvo, Emiliano, Penel, Nicolas, Krebs, Matthew G., Herbst, Roy S., Walgren, Richard A., Widau, Ryan C., Mi, Gu, Jin, Jin, Ferry, David, Chau, Ian
Publicado no Oncologist (2018)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

Por Reig, Maria, Galle, Peter R., Kudo, Masatoshi, Finn, Richard, Llovet, Josep M., Metti, Andrea L., Schelman, William R., Liang, Kun, Wang, Chunxiao, Widau, Ryan C., Abada, Paolo, Zhu, Andrew X.
Publicado no Liver Int (2020)

STING promotes homeostasis via regulation of cell proliferation and chromosomal stability

Por Ranoa, Diana Rose E., Widau, Ryan C., Mallon, Stephen, Parekh, Akash D., Nicolae, Claudia M., Huang, Xiaona, Bolt, Michael J., Arina, Ainhoa, Parry, Renate, Kron, Stephen J., Moldovan, George-Lucian, Khodarev, Nikolai N., Weichselbaum, Ralph R.
Publicado no Cancer Res (2018)

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

Por Widau, Ryan C., Parekh, Akash D., Ranck, Mark C., Golden, Daniel W., Kumar, Kiran A., Sood, Ravi F., Pitroda, Sean P., Liao, Zhengkai, Huang, Xiaona, Darga, Thomas E., Xu, David, Huang, Lei, Andrade, Jorge, Roizman, Bernard, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Publicado em 2014

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

Por Zhu, Andrew X., Finn, Richard S., Kang, Yoon-Koo, Yen, Chia-Jui, Galle, Peter R., Llovet, Josep M., Assenat, Eric, Brandi, Giovanni, Motomura, Kenta, Ohno, Izumi, Daniele, Bruno, Vogel, Arndt, Yamashita, Tatsuya, Hsu, Chih-Hung, Gerken, Guido, Bilbruck, John, Hsu, Yanzhi, Liang, Kun, Widau, Ryan C., Wang, Chunxiao, Abada, Paolo, Kudo, Masatoshi
Publicado no Br J Cancer (2021)

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

Por Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
Publicado no JHEP Rep (2020)